Herbal Hair Gel Formulation with 5α-Reductase Inhibitory Activity and Standardization by HPTLC

    Arpan Chakraborty, Arka Bhattacharjee
    Image of study
    TLDR The herbal hair gel could be a safe hair growth treatment with minimal side effects.
    In 2016, researchers formulated a herbal hair gel designed to treat alopecia by inhibiting 5α-reductase, an enzyme involved in hair loss. The gel was composed of 1% Hibiscus rosa-sinensis flower extract, 1% Eclipta alba whole plant extract, and 0.5% Solanum nigrum plant berries extract. It exhibited favorable physical properties with a pH of 6.68, viscosity of 4731 cps, and spreadability of 11.05 g-cm/sec, and caused no skin irritation. The active compounds quercetin, ß-sitosterol, and linoleic acid were quantified using High-Performance Thin Layer Chromatography (HPTLC) at concentrations of 0.120%, 0.1377%, and 0.379% w/w, respectively. The study concluded that the gel could be a safe alternative to conventional drugs for hair growth with minimal side effects, and the HPTLC method could be applied for standardizing these compounds in similar formulations.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 97 results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 4 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

    Related Research

    1 / 1 results